Concepedia

Christopher Trabbic

CT

Statistics

Publications

10

Citations

483

H-Index

10

Active since

2013

Affiliations

University of Toledo(Current)

University of Minnesota Medical Center

Christopher Trabbic is an author at University of Toledo specializing in pharmacology, cancer pharmacology, and medicine.

ORCID

Publications per year

2013–2019

10

Publications

10

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

David E. Stec, Kezia John, Christopher Trabbic et al. · PLoS ONE · 2016 · 185 citations · Full text

, , +17

Differential Induction of Cytoplasmic Vacuolization and Methuosis by Novel 2-Indolyl-Substituted Pyridinylpropenones

Christopher Trabbic, Heather M. Dietsch, Evan Alexander et al. · ACS Medicinal Chemistry Letters · 2013 · 58 citations

, , +16

The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma

Zehui Li, Nneka E. Mbah, Jean H. Overmeyer et al. · BMC Cancer · 2019 · 51 citations · Full text

, , +17

Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells

Joshua Heyza, Sanjeevani Arora, Hao Zhang et al. · Nutrients · 2018 · 50 citations · Full text

, , +13

Synthesis and Biological Evaluation of Indolyl-Pyridinyl-Propenones Having Either Methuosis or Microtubule Disruption Activity

Christopher Trabbic, Jean H. Overmeyer, Evan Alexander et al. · Journal of Medicinal Chemistry · 2015 · 48 citations · Full text

, , +10

1–5 of 10